DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,070 | +22.4% | 162,699 | +35.5% | 0.18% | +4.7% |
| Q2 2023 | $1,691 | +7.1% | 120,095 | +17.5% | 0.17% | +8.3% |
| Q1 2023 | $1,579 | +41.1% | 102,231 | +49.7% | 0.16% | +12.2% |
| Q4 2022 | $1,119 | -99.6% | 68,289 | +379.3% | 0.14% | +297.1% |
| Q3 2022 | $264,000 | -19.5% | 14,247 | -42.8% | 0.04% | -28.6% |
| Q2 2022 | $328,000 | +89.6% | 24,923 | +33.2% | 0.05% | +113.0% |
| Q1 2022 | $173,000 | +15.3% | 18,713 | +21.6% | 0.02% | +21.1% |
| Q4 2021 | $150,000 | -92.7% | 15,388 | -74.6% | 0.02% | -91.0% |
| Q3 2021 | $2,057,000 | +637.3% | 60,550 | +1138.2% | 0.21% | +356.5% |
| Q4 2020 | $279,000 | -29.0% | 4,890 | -48.8% | 0.05% | -53.5% |
| Q1 2020 | $393,000 | – | 9,548 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |